Translation: Researchers will continue to pursue it, but its not ready for primetime
[3] Initial treatment of pernicious anemia typically consists of 1,000 mcg intramuscularly daily for one week, then weekly for four weeks, transitioning to 1,000 mcg monthly for life
However, in resistant patients, oxidative stress causes a conformational change in Keap1, leading to the release of NRF2, which translocates to the nucleus and binds to antioxidant response element (ARE), activating the expression of downstream antioxidant genes, including GPX4, NQO1, HO-1 and SOD1 [33], and promoting the synthesis of GSH, as illustrated in Fig
And there's a variety of different SNPs that show people
It is the FDAs way of flagging a substance that may present significant safety risks when used in compounding
For musculoskeletal healing, injectable forms have far superior systemic bioavailability and are the standard for research